Vericel (VCEL) Intangibles (2014 - 2026)
Vericel (VCEL) reported Intangibles of $5.5 million for Q1 2026, down 10.26% on a YoY basis from $6.1 million in Q1 2025, and down 2.77% sequentially from $5.6 million in Q4 2025.
Vericel (VCEL) Intangibles (2014 - 2026) Analysis & Trends
Vericel (VCEL) has 8 years of Intangibles data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 10.26% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 10.26% YoY), and the FY2025 full-year result was $5.6 million, down 10.0% from the prior year.
- Intangibles declined to $5.5 million in Q1 2026, from $5.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.5 million in Q4 2022 to a low of $5.5 million in Q1 2026.
- A 5-year average of $6.5 million and a median of $6.5 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles decreased 8.33% in 2023 and fell 10.26% in 2026, its largest moves.
- Tracing VCEL's Intangibles over 5 years: stood at $7.5 million in 2022, then slipped by 8.33% to $6.9 million in 2023, then retreated by 9.09% to $6.2 million in 2024, then decreased by 10.0% to $5.6 million in 2025, then decreased by 2.77% to $5.5 million in 2026.
- Business Quant data shows VCEL's Intangibles at $5.5 million in Q1 2026, $5.6 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 5.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 5.78 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 6.56 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 7.34 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Sep 30, 2016 | 2.71 Mn |
| Jun 30, 2016 | 2.78 Mn |
| Mar 31, 2016 | 2.85 Mn |
| Dec 31, 2015 | 2.92 Mn |
| Sep 30, 2015 | 2.99 Mn |
| Jun 30, 2015 | 3.06 Mn |